Cocrystal Pharma SG&A Expense (TTM) Insights

Cocrystal Pharma Inc (COCP)

1.77 +0.06 (+3.51%) USD | NASDAQ | Sep 27, 16:00

1.74 -0.03 (-1.69%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2008. Upgrade now.

Date	Value
June 30, 2024	5.596M
March 31, 2024	5.994M
December 31, 2023	5.99M
September 30, 2023	5.806M
June 30, 2023	5.779M
March 31, 2023	5.616M
December 31, 2022	5.745M
September 30, 2022	5.499M
June 30, 2022	5.525M
March 31, 2022	5.421M
December 31, 2021	5.249M
September 30, 2021	5.558M
June 30, 2021	4.831M
March 31, 2021	5.588M
December 31, 2020	5.566M
September 30, 2020	5.554M
June 30, 2020	5.656M
March 31, 2020	4.679M
December 31, 2019	4.863M
September 30, 2019	4.792M
June 30, 2019	4.521M
March 31, 2019	4.483M
December 31, 2018	4.35M
September 30, 2018	3.883M
June 30, 2018	3.648M

Date	Value
March 31, 2018	2.58M
December 31, 2017	2.44M
September 30, 2017	2.222M
June 30, 2017	1.306M
March 31, 2017	3.197M
December 31, 2016	4.139M
September 30, 2016	6.492M
June 30, 2016	8.128M
March 31, 2016	8.19M
December 31, 2015	6.833M
September 30, 2015	4.29M
June 30, 2015	3.206M
March 31, 2015	1.807M
December 31, 2014	1.737M
September 30, 2014	1.477M
June 30, 2014	1.179M
March 31, 2014	0.731M
December 31, 2013	0.219M
September 30, 2013	-2.421M
June 30, 2013	-1.064M
March 31, 2013	0.4464M
December 31, 2012	2.208M
September 30, 2012	4.223M
June 30, 2012	7.109M
March 31, 2012	6.837M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

4.679M

Minimum

Mar 2020

5.994M

Maximum

Mar 2024

5.465M

Average

5.562M

Median

SG&A Expense (TTM) Benchmarks